ATHE
Closed
Alterity Therapeutics Ltd
4.0098
-0.0786 (-1.92%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.0884
Day's Range: 3.9 - 4.1686
Send
sign up or login to leave a comment!
When Written:
2.7764
Alterity Therapeutics Ltd is a biotechnology company based in Australia that is focused on developing treatments for neurodegenerative diseases. The company's lead drug candidate, PBT434, is being developed to treat Parkinson's disease and other related disorders. PBT434 works by targeting the accumulation of iron in the brain, which is believed to contribute to the development of these diseases. Alterity Therapeutics also has a pipeline of other drug candidates targeting neurodegenerative diseases, including Alzheimer's disease and multiple system atrophy. The company was founded in 1997 and is headquartered in Melbourne, Australia.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








